Abstract:
PROBLEM TO BE SOLVED: To provide a new osmium-based electrochemical species for detecting a wide variety of analytes using immunological techniques using an electrochemical oxidation/reduction label (also called an electron transfer agent or an electrochemical mediator label). SOLUTION: The new osmium-based electrochemical species usable in an immunoassay is provided. The osmium species can bond with a specific binding ligand for detecting related analytes and further can contain 1, 2 or 4 osmium centers that bond with the specific binding ligand using various bonding groups. Test sensors and diagnostic kits supporting electrode structures that can be used with the osmium-based electrochemical species are also provided. The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of the electrical signal desired to analyze analytes that may be present at low concentration. COPYRIGHT: (C)2011,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide novel osmium-based electrochemical species for the detection of wide variety of analytes by using immunological technologies. SOLUTION: Compounds such as compound 57 are provided. The electrochemical species may contain 1, 2, or 4 osmium centers which bind to specifically binding ligands by using various connecting groups. COPYRIGHT: (C)2011,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide novel osmium-based electrochemical species for the detection of a wide variety of analytes using immunological techniques, and provide a test sensor and diagnostic kit for supporting electrode structures that can be used with the osmium-based electrochemical species. SOLUTION: The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of an electrical signal desired to analyze analytes that may be present at low concentrations. COPYRIGHT: (C)2011,JPO&INPIT
Abstract:
The present disclosure relates to various methods for measuring the amount of an analyte present in a biological fluid using an electrochemical testing process. Various embodiments are disclosed, including the use of AC test signals and the performance of tests having a Total Test Time within about 2.0 seconds or less, and/or having a clinically low Total System Error.
Abstract:
An electrochemical biosensor (210) with electrode elements (274, 276) that possess smooth, high-quality edges (281, 283, 285, 287) with an edge definition better than 6µm. These smooth edges define gaps between electrodes, electrode traces and contact pads. Due to the remarkable edge smoothness achieved, the gaps can be quite small, which provides marked advantages in terms of test accuracy, speed and the number of different functionalities that can be packed into a single biosensor. Further, the present application provides a biosensor production method in which entire electrode patterns for the inventive biosensors can be formed all at one, in nanoseconds - without regard to the complexity of the electrode patterns or the amount of conductive material that must be ablated to form them.
Abstract:
Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
Abstract:
The present invention provides novel osmium-based electrochemical species for the detection of wide variety of analytes using immunological techniques. The present invention also provides diagnostic kits and test sensors supporting electrode structures that can be used with the osmium-based electrochemical species. The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of the electrical signal amplification desired to analyze analytes that may be present at low concentrations.
Abstract:
Systems and methods for multiple analyte analysis are provided. In one embodiment, a method includes determining concentrations of first and second analytes in a sample. The first and second analytes may be, for example, glucose and hydroxybutyrate. In this form, an indication related to the measured concentration of hydroxybutyrate is provided in response to determining that the concentration of hydroxybutyrate is above a predetermined value. In a further aspect of this form, a quantitative indication representative of the measured glucose concentration is automatically provided regardless of the value of the measured glucose concentration. In another embodiment, a system includes a meter configured to interact with a test element to assess first and second analytes in a sample. Further embodiments, forms, objects, features, advantages, aspects, and benefits shall become apparent from the description and drawings.
Abstract:
Some embodiments of the invention include a 2 -up manufacturing technique for producing test strips (100) to reduce costs, reduce waste, and increase output. Other techniques relating to the 2 -up technique, such as simultaneously manufacturing test strips (100) arranged in multiple columns, are also disclosed. Yet other techniques include cutting through the upper (110) and lower substrates (130) to form an overhang of either the upper (110) or the lower substrate (130). Other embodiments include a dual -use biosensor in which a user can apply a sample of bodily fluid to both test strips simultaneously.
Abstract:
The present disclosure relates to various methods for measuring the amount of an analyte present in a biological fluid using an electrochemical testing process. Various embodiments are disclosed, including the use of AC test signals and the performance of tests having a Total Test Time within about 2.0 seconds or less, and/or having a clinically low Total System Error.